Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31707350 | 1.00 | ABCB11 (0.57) | ABCB11LMNAPTGS1ADORA1PTGS2 | |
| SCHEMBL30549386 | 0.86 | MAPT (0.50) | LMNAPTGS1PTGS2GAAMAPT | |
| SCHEMBL16979055 | 0.86 | ABCB11 (0.57) | ABCB11LMNAPTGS1ADORA1PTGS2 | |
| SCHEMBL27722742 | 0.86 | ABCB11 (0.51) | ABCB11LMNAPTGS1ADORA1PTGS2 | |
| SCHEMBL13241358 | 0.85 | ABCB11 (0.74) | ABCB11LMNAPTGS1ADORA1PTGS2 | |
| SCHEMBL9999972 | 0.85 | ABCB11 (0.61) | ABCB11LMNAPTGS1ADORA1PTGS2 | |
| SCHEMBL3002445 | 0.85 | CES2 (0.47) | ABCB11LMNAPTGS1ADORA1PTGS2 | |
| SCHEMBL4459472 | 0.85 | ABCB11 (0.56) | ABCB11LMNAPTGS1ADORA1PTGS2 | |
| Amfenac SCHEMBL30777846 | 0.85 | ABCB11 (0.78) | ABCB11LMNAPTGS1ADORA1PTGS2 | |
| Amfenac SCHEMBL24249 | 0.85 | ABCB11 (0.78) | ABCB11LMNAPTGS1ADORA1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109673-A1 | ACETYL-COA CARBOXYLASE MODULATORS | MONSANTO TECHNOLOGY LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12448355-B2 | Acetyl-CoA carboxylase modulators | MONSANTO TECHNOLOGY LLC (US) | 2025-10-21 | — | — | US | disclosed |
| WO-2022199625-A1 | PHOTOSENSITIVE RESIN COMPOSITION HAVING IMPROVED SYSTEM HUE STABILITY | 常州正洁智造科技有限公司 | 2022-09-29 | — | — | WO | disclosed |
| US-20210246106-A1 | ACETYL-COA CARBOXYLASE MODULATORS | MONSANTO TECHNOLOGY LLC (US) | 2021-08-12 | — | — | US | disclosed |
| WO-2021104224-A1 | EO/PO-MODIFIED 9-PHENYLACRIDINE PHOTOSENSITIZER AND APPLICATION THEREOF | 常州强力电子新材料股份有限公司 | 2021-06-03 | — | — | WO | disclosed |
| US-10995070-B2 | Acetyl-CoA carboxylase modulators | MONSANTO TECHNOLOGY LLC (US) | 2021-05-04 | — | — | US | disclosed |
| WO-2020233700-A1 | HABI PHOTOINITIATOR CAPABLE OF IMPROVING SYSTEM STABILITY AND APPLICATION THEREOF | 常州格林感光新材料有限公司 (CN) | 2020-11-26 | — | — | WO | disclosed |
| WO-2020200020-A1 | HEXAARYLBIIMIDAZOLE PHOTOINITIATOR AND APPLICATION THEREOF | 常州格林感光新材料有限公司 | 2020-10-08 | — | — | WO | disclosed |
| CN-104749882-B | Coloring composition, colored cured film, and display element | JSR株式会社 | 2020-01-31 | — | — | CN | disclosed |
| US-20190135757-A1 | ACETYL-COA CARBOXYLASE MODULATORS | MONSANTO TECHNOLOGY LLC (US) | 2019-05-09 | — | — | US | disclosed |
| CN-103906735-A | Novel aryl-quinoline derivatives | HOFFMANN LA ROCHE | 2014-07-02 | — | — | CN | disclosed |
| US-8461263-B2 | End-modified diene copolymer having good compatibility with reinforcing silica and preparation method thereof | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2013-06-11 | — | — | US | disclosed |
| WO-2013064465-A1 | NEW ARYL-QUINOLINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2013-05-10 | — | — | WO | disclosed |
| WO-2013064465-A1 | NEW ARYL-QUINOLINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2013-05-10 | — | — | WO | disclosed |
| US-20130116234-A1 | ARYL-QUINOLINE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2013-05-09 | — | — | US | disclosed |
| US-20130116234-A1 | ARYL-QUINOLINE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2013-05-09 | — | — | US | disclosed |
| US-20130116234-A1 | ARYL-QUINOLINE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2013-05-09 | — | — | US | disclosed |
| US-20130090427-A1 | END-MODIFIED DIENE COPOLYMER HAVING GOOD COMPATIBILITY WITH REINFORCING SILICA AND PREPARATION METHOD THEREOF | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2013-04-11 | — | — | US | disclosed |
| US-4898874-A | Acetic acid derivatives of 3-aryl-2,1-benzisoxazole and esters and amides thereof | A. H. ROBINS COMPANY, INC. (US) | 1990-02-06 | — | — | US | disclosed |
| EP-0260924-A1 | Antiinflammatory derivatives of 3-aryl-2,1-benzisoxazole | A.H. ROBINS COMPANY, INCORPORATED (US) | 1988-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246106-A1 | ACETYL-COA CARBOXYLASE MODULATORS | ACACA, ACACB, ACAT2 | ABCB11 4157/4885LMNA 4101/4885PTGS1 2570/4885 |
| US-12448355-B2 | Acetyl-CoA carboxylase modulators | ACACA, ACACB, ACAT2 | ABCB11 4157/4885LMNA 4101/4885PTGS1 2570/4885 |
| US-20130116234-A1 | ARYL-QUINOLINE DERIVATIVES | FABP1, FABP4, FABP5 | ABCB11 1826/4885LMNA 1769/4885PTGS1 2518/4885 |
| US-20190135757-A1 | ACETYL-COA CARBOXYLASE MODULATORS | ACACA, ACACB, ACAT2 | ABCB11 4157/4885LMNA 4101/4885PTGS1 2570/4885 |
| US-10995070-B2 | Acetyl-CoA carboxylase modulators | ACACA, ACACB, ACAT2 | ABCB11 4157/4885LMNA 4101/4885PTGS1 2570/4885 |
| US-20260109673-A1 | ACETYL-COA CARBOXYLASE MODULATORS | ACACA, ACACB, HACL2 | ABCB11 1464/4885LMNA 3615/4885PTGS1 3585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.